Daniel Kreisel MD PhD
Cardiovascular Surgery
Professor, Surgery, Pathology & Immunology, Surgical Director, Lung Transplant Program, Washington University School of Medicine
Join to View Full Profile
1 Barnes Jewish Hospital Plz# DivSaint Louis, MO 63110
Phone+1 314-362-7260
Fax+1 314-362-6288
Dr. Kreisel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Thoracic Surgery - Independent, 2003 - 2005
University of Pennsylvania Health SystemResidency, Surgery, 1995 - 2003
Icahn School of Medicine at Mount SinaiClass of 1995
Certifications & Licensure
MO State Medical License 2005 - 2026
PA State Medical License 1996 - 2006
American Board of Surgery Surgery
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2012
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Utility of Routine Cervical Mediastinoscopy in Clinical Stage I Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2008 Jan 01
- Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs Start of enrollment: 2011 May 01
- Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Use of a novel donor lung scoring system as a tool for increasing lung recovery for transplantation.Yun Zhu Bai, Yan Yan, Su-Hsin Chang, Zhizhou Yang, Anjana Delhi
The Journal of Thoracic and Cardiovascular Surgery. 2025-04-01 - Tissue-resident CCR2macrophage TREM-1/3 signaling is necessary for monocyte and neutrophil recruitment to injured hearts.Yuriko Terada, Wenjun Li, Junedh M Amrute, Amit I Bery, Charles R Liu
Cell Reports. 2025-03-25 - Maintenance of graft tissue-resident Foxp3+ cells is necessary for lung transplant tolerance in mice.Wenjun Li, Yuriko Terada, Yun Zhu Bai, Yuhei Yokoyama, Hailey M Shepherd
The Journal of Clinical Investigation. 2025-03-18
Journal Articles
- Neutrophil Extracellular Trap Fragments Stimulate Innate Immune Responses That Prevent Lung Transplant ToleranceDaniel Kreisel, Yizhan Guo, Alexander S Krupnick, American journal of transplantation
- Bronchiolitis-Obliterans Syndrome-Free Survival Following Lung Transplantation - an International Society for Heart and Lung Transplantation (ISHLT) Thoracic Transplan...Daniel E Kreisel, Varun Puri, Benjamin D Kozower, G Alec Patterson, The Journal of Heart and Lung Transplantation
- The Human Heart Contains Distinct Macrophage Subsets with Divergent Origins and FunctionsDaniel Kreisel, Stavros G Drakos, Kory J Lavine, Craig H Selzman, Nature
Authored Content
- Bronchiolitis-Obliterans Syndrome-Free Survival Following Lung Transplantation - an International Society for Heart and Lung Transplantation (ISHLT) Thoracic Transplant Registry AnalysisSeptember 2018
Press Mentions
Researchers Receive $22 Million Grant for Clinical Trial That Aims to Reduce Lung Transplant RejectionNovember 18th, 2021- NIH Grants $10M to Study Immune Cells’ Role in Lung, Heart Transplant RejectionSeptember 4th, 2020
- $10 Million in Grants Aimed at Preventing Organ Rejection After TransplantationSeptember 1st, 2020
- Join now to see all
Grant Support
- Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With ClazakizumabMASSACHUSETTS GENERAL HOSPITAL2021–2028
- Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With ClazakizumabMASSACHUSETTS GENERAL HOSPITAL2021–2028
- Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With ClazakizumabMASSACHUSETTS GENERAL HOSPITAL2021–2028
- Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With ClazakizumabMASSACHUSETTS GENERAL HOSPITAL2021–2028
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- The Role of Donor Innate Immune Responses in Regulating Alloimmunity after Heart TransplantationWASHINGTON UNIVERSITY2020–2025
- Pathways Regulating Lung Transplant Tolerance.WASHINGTON UNIVERSITY2015–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
